title: Long-term prazosin therapy for COPD pulmonary hypertension.
abstract: A 51-year-old patient with COPD, obesity, and pulmonary hypertension underwent long-term prazosin therapy after a successful hemodynamic response to 1 mg of oral prazosin. The 18-month administration of prazosin, in a dose of 3 mg a day, resulted in continued hemodynamic and echocardiographic benefits.
authors.affiliation: Department of Cardiology and Medicine, County Hospital, Wrocław, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Lewczuk
authors.forename: B
authors.initials: B
authors.lastname: Sobkowicz-Woźniak
authors.forename: P
authors.initials: P
authors.lastname: Piszko
authors.forename: J
authors.initials: J
authors.lastname: Spikowski
authors.forename: K
authors.initials: K
authors.lastname: Wrabec
mesh_terms: D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000188:drug therapy; D011224:Prazosin / Q000627:therapeutic use*; D012074:Remission Induction; D013997:Time Factors
chemical_list: D011224:Prazosin